What works quickly for one person might have a more gradual impact on another
If your appetite suppression weakens, your weight loss stalls, or your expected monthly results fall short without any other explanation, degraded medication should be investigated
PlexusDx genetic testing can identify peptide-pathway variants that influence your risk for atypical reactions, allowing your provider to adjust your treatment approach
We conclude that a GST 4QN tag could improve the reproducibility and reliability of proteinprotein interaction studies without compromising GSH affinity
These findings have important clinical implications, as they suggest that GLP-1 analogs could be a viable treatment option for patients with MSH, PSW, or other forms of obesity resulting from MC4R deficiencies
By expanding access to FDA-approved obesity medications for Medicaid enrollees, TennCares actions clearly signal that we believe people living with obesity deserve evidence-based care, not judgment or denial